Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob S Rozowsky

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Free Neuropathology|June 7, 2023
Neurooncology: 2022 updatePieter Wesseling, Jacob S Rozowsky
Cancers|January 23, 2024
APOBEC Mutagenesis in Cancer Development and SusceptibilityAlexandra Dananberg, Josefine Striepen, Jacob S Rozowsky, et al.
Trends in Cancer|April 4, 2026
Toward mutational epidemiology: using mutational signatures of environmental exposures to assess cancer riskFiona Sherman, Jacob S Rozowsky, Arinze Okafor, et al.
Frontiers in Immunology|April 25, 2022
A Toolkit for Profiling the Immune Landscape of Pediatric Central Nervous System MalignanciesJacob S Rozowsky, Joyce I Meesters-Ensing, Julie A S Lammers, et al.
Neuro-Oncology|July 29, 2025
Multi-modal analysis of pediatric pilocytic astrocytomas reveals tumor location-associated cellular and transcriptional heterogeneityJulie A S Lammers, Jacob S Rozowsky, Friso G Calkoen, et al.
Biorxiv : the Preprint Server for Biology|February 25, 2026
Single-cell multidimensional profiling of tumor cell heterogeneity in supratentorial ependymomasDaeun Jeong, Sara G Danielli, Kendra K Maaß, et al.
Nature|May 6, 2026
Author Correction: Multidimensional profiling of heterogeneity in supratentorial ependymomasDaeun Jeong, Sara G Danielli, Kendra K Maaß, et al.
Nature|March 12, 2026
Multidimensional profiling of heterogeneity in supratentorial ependymomasDaeun Jeong, Sara G Danielli, Kendra K Maaß, et al.
Cell Reports. Medicine|May 2, 2025
Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressureJenna J LaBelle, Rebecca D Haase, Alexander Beck, et al.
Cancer Cell|March 14, 2025
Effective targeting of PDGFRA-altered high-grade glioma with avapritinibLisa Mayr, Sina Neyazi, Kallen Schwark, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Free Neuropathology|June 7, 2023
Neurooncology: 2022 updatePieter Wesseling, Jacob S Rozowsky
Cancers|January 23, 2024
APOBEC Mutagenesis in Cancer Development and SusceptibilityAlexandra Dananberg, Josefine Striepen, Jacob S Rozowsky, et al.
Trends in Cancer|April 4, 2026
Toward mutational epidemiology: using mutational signatures of environmental exposures to assess cancer riskFiona Sherman, Jacob S Rozowsky, Arinze Okafor, et al.
Frontiers in Immunology|April 25, 2022
A Toolkit for Profiling the Immune Landscape of Pediatric Central Nervous System MalignanciesJacob S Rozowsky, Joyce I Meesters-Ensing, Julie A S Lammers, et al.
Neuro-Oncology|July 29, 2025
Multi-modal analysis of pediatric pilocytic astrocytomas reveals tumor location-associated cellular and transcriptional heterogeneityJulie A S Lammers, Jacob S Rozowsky, Friso G Calkoen, et al.
Biorxiv : the Preprint Server for Biology|February 25, 2026
Single-cell multidimensional profiling of tumor cell heterogeneity in supratentorial ependymomasDaeun Jeong, Sara G Danielli, Kendra K Maaß, et al.
Nature|May 6, 2026
Author Correction: Multidimensional profiling of heterogeneity in supratentorial ependymomasDaeun Jeong, Sara G Danielli, Kendra K Maaß, et al.
Nature|March 12, 2026
Multidimensional profiling of heterogeneity in supratentorial ependymomasDaeun Jeong, Sara G Danielli, Kendra K Maaß, et al.
Cell Reports. Medicine|May 2, 2025
Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressureJenna J LaBelle, Rebecca D Haase, Alexander Beck, et al.
Cancer Cell|March 14, 2025
Effective targeting of PDGFRA-altered high-grade glioma with avapritinibLisa Mayr, Sina Neyazi, Kallen Schwark, et al.
Pageof 1